Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
- 1 March 2005
- journal article
- clinical trial
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 2 (3) , 134-135
- https://doi.org/10.1038/ncponc0104
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- The pathobiology of mucositisNature Reviews Cancer, 2004
- Effect of Recombinant Human Keratinocyte Growth Factor (rHuKGF) on the Immunopathogenesis of Intestinal Graft-Vs.-Host Disease Induced Without a Preconditioning RegimenJournal of Clinical Immunology, 2004
- Nrf2 Transcription Factor, a Novel Target of Keratinocyte Growth Factor Action Which Regulates Gene Expression and Inflammation in the Healing Skin WoundMolecular and Cellular Biology, 2002